SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D/A
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
(Amendment No. 12)1
WILHELMINA INTERNATIONAL, INC.
(Name of Issuer)
COMMON STOCK, $0.01 PAR VALUE
(Title of class of securities)
968235200
(CUSIP number)
Mark E. Schwarz
NCM Services, Inc.
5420 Lyndon B Johnson... (continue reading...)
More SEC Filings
View Older Stories-
Form DEFA14A NORFOLK SOUTHERN CORP
-
Form DEF 14A LAUREATE EDUCATION, INC. For: May 30
-
Form 3 abrdn Life Sciences Inve For: Apr 18 Filed by: Saba Capital Management, L.P.
-
Form 6-K Alvotech For: Apr 19
-
Form 4 First Bancorp, Inc /ME/ For: Apr 18 Filed by: Swan Kimberly
-
Form 6-K British American Tobacco For: Apr 19
-
Form 8-K Ellington Credit Co For: Apr 18
-
Form 6-K ZTO Express (Cayman) For: Apr 19
-
Form 6-K YS Biopharma Co., Ltd. For: Apr 19
-
Form ARS Jamf Holding Corp. For: Dec 31
-
Form 8-K AQUABOUNTY TECHNOLOGIES For: Apr 18
-
Form 8-K VAIL RESORTS INC For: Apr 19
-
Form D/A Liberty Hall Capital NL
-
Form DEFA14A Jamf Holding Corp.
-
Form DEFA14A Elanco Animal Health
-
Form DEF 14A Elanco Animal Health For: May 30
-
Form DEF 14A Jamf Holding Corp. For: May 30
-
Form DEF 14A INTERNATIONAL TOWER HILL For: May 29
-
Form DEF 14A PRIMEENERGY RESOURCES For: Jun 05
-
Form 8-K CUMULUS MEDIA INC For: Apr 18
-
Form 6-K Steakholder Foods Ltd. For: Apr 19
-
Form 20-F Concord Medical Services For: Dec 31
-
Form ARS Karyopharm Therapeutics For: Dec 31
-
Form D/A Chameleon Global Fund
-
Form D/A Chameleon Global Fund
-
Form DEFA14A NORFOLK SOUTHERN CORP
-
Form 8-K/A Ayala Pharmaceuticals, For: Mar 25
-
Form 6-K ICICI BANK LTD For: Apr 12
-
Form 6-K Baozun Inc. For: Apr 19
-
Form 424B3 Volato Group, Inc.
-
Form DEFA14A Karyopharm Therapeutics
-
Form S-4/A ORRSTOWN FINANCIAL SERVI
-
Form D/A Bergamot Music Fund I
-
Form 4 abrdn Global Infrastruct For: Apr 18 Filed by: Goodson Alan R
-
Form ARS Verrica Pharmaceuticals For: Dec 31
-
Form ARS FTI CONSULTING, INC For: Dec 31
-
Form MA-A UniBank Fiscal Advisory For: Dec 31
-
Form DEF 14A Karyopharm Therapeutics For: May 29
-
Form D/A Noetic Fund II (US), LP
-
Form DEFA14A Verrica Pharmaceuticals
-
Form DEFA14A Apartment Income REIT
-
Form DEFA14A FTI CONSULTING, INC
-
Form DEF 14A FTI CONSULTING, INC For: Jun 05
-
Form 8-K Apartment Income REIT, For: Apr 19 Filed by: Apartment Income REIT Corp.
-
Form DEF 14A Verrica Pharmaceuticals For: Jun 06
-
Form D/A FCOI II Currency Class
-
Form 6-K DR REDDYS LABORATORIES For: Apr 19
-
Form 6-K Baozun Inc. For: Apr 19
-
Form D/A Candriam Global Emerging
-
Form 8-K AMCON DISTRIBUTING CO For: Apr 18